<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04060615</url>
  </required_header>
  <id_info>
    <org_study_id>61206-1296/2-17</org_study_id>
    <nct_id>NCT04060615</nct_id>
  </id_info>
  <brief_title>Properties of Myocardial Microcirculation in Patients With Different Pathomorphological Substrates, Before and After Recanalization of Coronary Artery CTO</brief_title>
  <official_title>Properties of Myocardial Microcirculation in Patients With Different Pathomorphological Substrates, Before and After Recanalization of Coronary Artery Chronic Total Occlusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Belgrade</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinical Centre of Serbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Belgrade</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the changes in myocardial microcirculatory parameters of the
      collateral donor artery after recanalization of coronary artery chronic total occlusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will include patients with chronic total occlusion (CTO) of one coronary artery
      who will undergo the recanalization of the CTO. Before the procedure, myocardial viability,
      ischemia, functional parameters of the collateral donor blood vessels, echocardiography, and
      quality of life will be assessed. After the recanalization, these parameters will be assessed
      again 24h and 6 months after the procedure.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 28, 2017</start_date>
  <completion_date type="Anticipated">January 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All patients with chronic total occlusion will undergo the PCI procedure of the occlusion.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Coronary flow reserve</measure>
    <time_frame>six months</time_frame>
    <description>Change in coronary flow reserve of the collateral donor vessel (after PCI as compared to values before PCI) will be regarded as primary outcome measure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Coronary flow velocity reserve</measure>
    <time_frame>six months</time_frame>
    <description>Correlation of coronary flow velocity reserve change of the collateral donor vessel (after PCI as compared to values before PCI) with viability measured by the percentage of viable myocardium on Single Photon Emission Computed Tomography (SPECT) of myocardial perfusion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wall Motion Score Index (WMSI)</measure>
    <time_frame>six months</time_frame>
    <description>Relation of coronary flow velocity reserve change with wall motion score index on stres-echocardyography test where the wall motion segment abnormalities will be graded as such: 1 - normokinesis, 2 - hypokinesis, 3- akinesis and 4 dyskinesis, and the higher values indicates worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Stable Angina questionnaire (SAQ) at 6 months</measure>
    <time_frame>six months</time_frame>
    <description>Relation of coronary flow velocity reserve change with the quality of life measured by 19-item Seattle Angina Questionnaire that assesses angina frequency (with 9 questions where answers range from 1 to 6, the total score ranges from 0 to 100, where the higher value indicates better outcome), angina stability ( with 1 question where answers range from 1 to 6, the total score ranges from 0 to 100, where the higher value indicates better outcome), the angina frequency scale (with 2 questions where answers range from 1 to 5, the total score ranges from 0 to 100, where the higher value indicates better outcome), treatment satisfaction (with 4 questions where answers range from 1 to 6, the total score ranges from 0 to 100, where the higher value indicates better outcome), and disease perception/QoL (with 3 questions where answers range from 1 to 5, the total score ranges from 0 to 100, where the higher value indicates better outcome)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Total Occlusion of Coronary Artery</condition>
  <arm_group>
    <arm_group_label>Patients with chronic total occlusion of the coronary artery</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In each patient before the PCI procedure, the investigators will assess myocardial viability, functional parameters of collateral blood vessels, and quality of life. 24h and 6 months after the procedure these parameters will be reevaluated as well as functional parameters of the treated coronary artery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>percutaneous coronary intervention</intervention_name>
    <description>PCI of the chronic total occlusion of the coronary artery</description>
    <arm_group_label>Patients with chronic total occlusion of the coronary artery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over the age of 18 with signed informed consent to participate in the study

          -  Presence of one CTO on native coronary arteries (with TIMI 0 flow)

          -  Presence of clinical indication for attempting a PCI for CTO (at least one of the
             criteria present):

               1. Symptoms of typical stable angina

               2. Presence of inducible ischemia in the territory of the occluded artery

               3. Presence of viable myocardium in the territory of the occluded artery

          -  The diameter of the occluded artery ≥2.5mm

        Exclusion Criteria:

          -  Acute coronary syndrome in the past month

          -  Existing contraindication for administration of dual antiplatelet therapy in the
             duration of 12 months

          -  Contraindications for implanting the drug-eluting stents

          -  Existence of 2 or more CTOs on native coronary arteries (with TIMI 0 flow)

          -  Severe tortuosity or calcifications of the coronary arteries

          -  Left ventricle aneurysm

          -  Previous coronary artery bay-pass graft or any other cardiac surgery

          -  Previous myocardial infarction in the coronary artery territory different from the CTO

          -  Ejection fraction of the left ventricle less than 30%

          -  Permanent atrial fibrillation

          -  Pregnancy

          -  Patients with known allergy to iodine contrast that cannot be controlled with
             medication

          -  Patients who are unable or unwilling to cooperate and come for check-up visits

          -  Life expectancy less than a year

          -  Hemorrhagic diathesis, coagulopathy, or rejection of blood transfusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Branko D Beleslin, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Belgrade</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miodrag C Ostojic, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Belgrade</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Centre of Serbia, University of Belgrade</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <reference>
    <citation>Sianos G, Werner GS, Galassi AR, Papafaklis MI, Escaned J, Hildick-Smith D, Christiansen EH, Gershlick A, Carlino M, Karlas A, Konstantinidis NV, Tomasello SD, Di Mario C, Reifart N; EuroCTO Club. Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club. EuroIntervention. 2012 May 15;8(1):139-45. doi: 10.4244/EIJV8I1A21. Review.</citation>
    <PMID>22580257</PMID>
  </reference>
  <reference>
    <citation>Delacrétaz E, Meier B. Therapeutic strategy with total coronary artery occlusions. Am J Cardiol. 1997 Jan 15;79(2):185-7.</citation>
    <PMID>9193021</PMID>
  </reference>
  <reference>
    <citation>Christofferson RD, Lehmann KG, Martin GV, Every N, Caldwell JH, Kapadia SR. Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol. 2005 May 1;95(9):1088-91.</citation>
    <PMID>15842978</PMID>
  </reference>
  <reference>
    <citation>Werner GS, Gitt AK, Zeymer U, Juenger C, Towae F, Wienbergen H, Senges J. Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present day clinical practice. Clin Res Cardiol. 2009 Jul;98(7):435-41. doi: 10.1007/s00392-009-0013-5. Epub 2009 Mar 18.</citation>
    <PMID>19294443</PMID>
  </reference>
  <reference>
    <citation>Fefer P, Knudtson ML, Cheema AN, Galbraith PD, Osherov AB, Yalonetsky S, Gannot S, Samuel M, Weisbrod M, Bierstone D, Sparkes JD, Wright GA, Strauss BH. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012 Mar 13;59(11):991-7. doi: 10.1016/j.jacc.2011.12.007.</citation>
    <PMID>22402070</PMID>
  </reference>
  <reference>
    <citation>Rathore S, Matsuo H, Terashima M, Kinoshita Y, Kimura M, Tsuchikane E, Nasu K, Ehara M, Asakura Y, Katoh O, Suzuki T. Procedural and in-hospital outcomes after percutaneous coronary intervention for chronic total occlusions of coronary arteries 2002 to 2008: impact of novel guidewire techniques. JACC Cardiovasc Interv. 2009 Jun;2(6):489-97. doi: 10.1016/j.jcin.2009.04.008.</citation>
    <PMID>19539251</PMID>
  </reference>
  <reference>
    <citation>Saito S. Progress in angioplasty for chronic total occlusions again. Catheter Cardiovasc Interv. 2010 Nov 15;76(6):850-1. doi: 10.1002/ccd.22847.</citation>
    <PMID>21104774</PMID>
  </reference>
  <reference>
    <citation>Godino C, Sharp AS, Carlino M, Colombo A. Crossing CTOs-the tips, tricks, and specialist kit that can mean the difference between success and failure. Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1019-46. doi: 10.1002/ccd.22161.</citation>
    <PMID>19950136</PMID>
  </reference>
  <reference>
    <citation>Werner GS. The role of coronary collaterals in chronic total occlusions. Curr Cardiol Rev. 2014 Feb;10(1):57-64. Review.</citation>
    <PMID>24611646</PMID>
  </reference>
  <reference>
    <citation>Werner GS, Bahrmann P, Mutschke O, Emig U, Betge S, Ferrari M, Figulla HR. Determinants of target vessel failure in chronic total coronary occlusions after stent implantation. The influence of collateral function and coronary hemodynamics. J Am Coll Cardiol. 2003 Jul 16;42(2):219-25.</citation>
    <PMID>12875755</PMID>
  </reference>
  <reference>
    <citation>Werner GS, Surber R, Kuethe F, Emig U, Schwarz G, Bahrmann P, Figulla HR. Collaterals and the recovery of left ventricular function after recanalization of a chronic total coronary occlusion. Am Heart J. 2005 Jan;149(1):129-37.</citation>
    <PMID>15660044</PMID>
  </reference>
  <reference>
    <citation>Werner GS, Surber R, Ferrari M, Fritzenwanger M, Figulla HR. The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction. Eur Heart J. 2006 Oct;27(20):2406-12. Epub 2006 Sep 26.</citation>
    <PMID>17003048</PMID>
  </reference>
  <reference>
    <citation>Werner GS, Fritzenwanger M, Prochnau D, Schwarz G, Ferrari M, Aarnoudse W, Pijls NH, Figulla HR. Determinants of coronary steal in chronic total coronary occlusions donor artery, collateral, and microvascular resistance. J Am Coll Cardiol. 2006 Jul 4;48(1):51-8. Epub 2006 Jun 12.</citation>
    <PMID>16814648</PMID>
  </reference>
  <reference>
    <citation>Werner GS, Ferrari M, Heinke S, Kuethe F, Surber R, Richartz BM, Figulla HR. Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions. Circulation. 2003 Apr 22;107(15):1972-7. Epub 2003 Mar 24.</citation>
    <PMID>12665484</PMID>
  </reference>
  <reference>
    <citation>Werner GS, Richartz BM, Gastmann O, Ferrari M, Figulla HR. Immediate changes of collateral function after successful recanalization of chronic total coronary occlusions. Circulation. 2000 Dec 12;102(24):2959-65.</citation>
    <PMID>11113046</PMID>
  </reference>
  <reference>
    <citation>Werner GS, Emig U, Bahrmann P, Ferrari M, Figulla HR. Recovery of impaired microvascular function in collateral dependent myocardium after recanalisation of a chronic total coronary occlusion. Heart. 2004 Nov;90(11):1303-9.</citation>
    <PMID>15486127</PMID>
  </reference>
  <reference>
    <citation>Zimarino M, Ausiello A, Contegiacomo G, Riccardi I, Renda G, Di Iorio C, De Caterina R. Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions. J Am Coll Cardiol. 2006 Jul 4;48(1):59-65. Epub 2006 Jun 12.</citation>
    <PMID>16814649</PMID>
  </reference>
  <reference>
    <citation>Sachdeva R, Uretsky BF. The effect of CTO recanalization on FFR of the donor artery. Catheter Cardiovasc Interv. 2011 Feb 15;77(3):367-9. doi: 10.1002/ccd.22806.</citation>
    <PMID>20853349</PMID>
  </reference>
  <reference>
    <citation>Kurisu S, Mitsuba N, Ishibashi K, Kato Y, Dohi Y, Nishioka K, Kihara Y. A pitfall of fractional flow reserve associated with the presence of collateral circulation. Intern Med. 2011;50(22):2811-3. Epub 2011 Nov 15.</citation>
    <PMID>22082894</PMID>
  </reference>
  <reference>
    <citation>Ladwiniec A, Hoye A. The haemodynamic effects of collateral donation to a chronic total occlusion: Implications for patient management. Int J Cardiol. 2015 Nov 1;198:159-66. doi: 10.1016/j.ijcard.2015.06.174. Epub 2015 Jul 6. Review.</citation>
    <PMID>26163908</PMID>
  </reference>
  <reference>
    <citation>Ladwiniec A, Cunnington MS, Rossington J, Mather AN, Alahmar A, Oliver RM, Nijjer SS, Davies JE, Thackray S, Alamgir F, Hoye A. Collateral donor artery physiology and the influence of a chronic total occlusion on fractional flow reserve. Circ Cardiovasc Interv. 2015 Apr;8(4). pii: e002219. doi: 10.1161/CIRCINTERVENTIONS.114.002219.</citation>
    <PMID>25805570</PMID>
  </reference>
  <reference>
    <citation>Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, Fihn SD. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995 Feb;25(2):333-41.</citation>
    <PMID>7829785</PMID>
  </reference>
  <reference>
    <citation>Pavlovic SV, Sobic-Saranovic DP, Beleslin BD, Ostojic MC, Nedeljkovic MA, Giga VL, Petrasinovic ZR, Artiko VM, Todorovic-Tirnanic MV, Obradovic VB. One-year follow-up of myocardial perfusion and function evaluated by gated SPECT MIBI in patients with earlier myocardial infarction and chronic total occlusion. Nucl Med Commun. 2009 Jan;30(1):68-75.</citation>
    <PMID>19306516</PMID>
  </reference>
  <reference>
    <citation>Gunning MG, Anagnostopoulos C, Davies G, Knight CJ, Pennell DJ, Fox KM, Pepper J, Underwood SR. Simultaneous assessment of myocardial viability and function for the detection of hibernating myocardium using ECG-gated 99Tcm-tetrofosmin emission tomography: a comparison with 201Tl emission tomography combined with cine magnetic resonance imaging. Nucl Med Commun. 1999 Mar;20(3):209-14.</citation>
    <PMID>10093069</PMID>
  </reference>
  <reference>
    <citation>Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, Van Train KF, Berman DS. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995 Nov;36(11):2138-47.</citation>
    <PMID>7472611</PMID>
  </reference>
  <reference>
    <citation>Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63.</citation>
    <PMID>16376782</PMID>
  </reference>
  <reference>
    <citation>Giga V, Dobric M, Beleslin B, Sobic-Saranovic D, Tesic M, Djordjevic-Dikic A, Stepanovic J, Nedeljkovic I, Artiko V, Obradovic V, Seferovic PM, Ostojic M. Estimation of infarct size using transthoracic Doppler echocardiographic measurement of coronary flow reserve in infarct related and reference coronary artery. Int J Cardiol. 2013 Sep 20;168(1):169-75. doi: 10.1016/j.ijcard.2012.09.099. Epub 2012 Oct 8.</citation>
    <PMID>23058345</PMID>
  </reference>
  <reference>
    <citation>Djordjevic-Dikic A, Beleslin B, Stepanovic J, Giga V, Tesic M, Dobric M, Stojkovic S, Nedeljkovic M, Vukcevic V, Dikic N, Petrasinovic Z, Nedeljkovic I, Tomasevic M, Vujisic-Tesic B, Ostojic M. Prediction of myocardial functional recovery by noninvasive evaluation of Basal and hyperemic coronary flow in patients with previous myocardial infarction. J Am Soc Echocardiogr. 2011 May;24(5):573-81. doi: 10.1016/j.echo.2011.01.004.</citation>
    <PMID>21514503</PMID>
  </reference>
  <reference>
    <citation>Beleslin B, Ostojic M, Djordjevic-Dikic A, Vukcevic V, Stojkovic S, Nedeljkovic M, Stankovic G, Orlic D, Milic N, Stepanovic J, Giga V, Saponjski J. The value of fractional and coronary flow reserve in predicting myocardial recovery in patients with previous myocardial infarction. Eur Heart J. 2008 Nov;29(21):2617-24. doi: 10.1093/eurheartj/ehn418. Epub 2008 Sep 30.</citation>
    <PMID>18826987</PMID>
  </reference>
  <reference>
    <citation>Baykan AO, Kalkan GY, Sahin DY, Elbasan Z, Gur M, Seker T, Turkoglu C, Caylı M. Coronary flow velocity reserve in donor artery and myocardial performance index after successful recanalization of chronic total coronary occlusions. J Invasive Cardiol. 2015 Jun;27(6):E75-81.</citation>
    <PMID>26028662</PMID>
  </reference>
  <reference>
    <citation>Schaper W. Collateral circulation: past and present. Basic Res Cardiol. 2009 Jan;104(1):5-21. doi: 10.1007/s00395-008-0760-x. Epub 2008 Dec 20. Review.</citation>
    <PMID>19101749</PMID>
  </reference>
  <reference>
    <citation>Matsuo H, Kawase Y. Physiological impact of CTO recanalization assessed by coronary pressure measurement: a case report. Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E459-64. doi: 10.1002/ccd.24842. Epub 2013 Apr 11.</citation>
    <PMID>23359324</PMID>
  </reference>
  <reference>
    <citation>Iqbal MB, Shah N, Khan M, Wallis W. Reduction in myocardial perfusion territory and its effect on the physiological severity of a coronary stenosis. Circ Cardiovasc Interv. 2010 Feb 1;3(1):89-90. doi: 10.1161/CIRCINTERVENTIONS.109.904193.</citation>
    <PMID>20160187</PMID>
  </reference>
  <reference>
    <citation>Melikian N, Cuisset T, Hamilos M, De Bruyne B. Fractional flow reserve--the influence of the collateral circulation. Int J Cardiol. 2009 Mar 6;132(3):e109-10. Epub 2007 Dec 4.</citation>
    <PMID>18055036</PMID>
  </reference>
  <reference>
    <citation>Sachdeva R, Agrawal M, Flynn SE, Werner GS, Uretsky BF. Reversal of ischemia of donor artery myocardium after recanalization of a chronic total occlusion. Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E453-8. doi: 10.1002/ccd.25031. Epub 2013 Jul 3.</citation>
    <PMID>23703834</PMID>
  </reference>
  <reference>
    <citation>Watanabe H, Saito N, Matsuo H, Kawase Y, Watanabe S, Bao B, Yamamoto E, Higami H, Nakatsuma K, Kimura T. In vitro assessment of physiological impact of recipient artery intervention on the contralateral donor artery. Cardiovasc Revasc Med. 2015 Mar;16(2):90-100. doi: 10.1016/j.carrev.2015.01.003. Epub 2015 Jan 30.</citation>
    <PMID>25870153</PMID>
  </reference>
  <reference>
    <citation>Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985 Mar;5(3):587-92.</citation>
    <PMID>3156171</PMID>
  </reference>
  <reference>
    <citation>TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985 Apr 4;312(14):932-6.</citation>
    <PMID>4038784</PMID>
  </reference>
  <reference>
    <citation>Hesse B, Lindhardt TB, Acampa W, Anagnostopoulos C, Ballinger J, Bax JJ, Edenbrandt L, Flotats A, Germano G, Stopar TG, Franken P, Kelion A, Kjaer A, Le Guludec D, Ljungberg M, Maenhout AF, Marcassa C, Marving J, McKiddie F, Schaefer WM, Stegger L, Underwood R. EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging. 2008 Apr;35(4):851-85. doi: 10.1007/s00259-007-0694-9.</citation>
    <PMID>18224320</PMID>
  </reference>
  <reference>
    <citation>Wahba FF, Bavelaar-Croon CD, Baur LH, Zwinderman AH, van Roosmalen RP, Pauwels EK, van der Wall EE. Detection of residual wall motion after sustained myocardial infarction by gated 99Tcm-tetrofosmin SPECT: a comparison with echocardiography. Nucl Med Commun. 2001 Feb;22(2):175-82.</citation>
    <PMID>11258404</PMID>
  </reference>
  <reference>
    <citation>Acampa W, Cuocolo A, Petretta M, Bruno A, Castellani M, Finzi A, Gerundini P. Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and Tl-201 scintigraphy. J Nucl Cardiol. 2002 Jan-Feb;9(1):33-40.</citation>
    <PMID>11845127</PMID>
  </reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 4, 2019</study_first_submitted>
  <study_first_submitted_qc>August 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2019</study_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Belgrade</investigator_affiliation>
    <investigator_full_name>Milan Dobric</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>chronic total occlusion</keyword>
  <keyword>coronary flow reserve</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 28, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/15/NCT04060615/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

